ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Channels More Money To CIS, 17 Offices Funded

March 9, 1990

DePinho Bets MD Anderson Credibility On His Cancer “Moon Shot” Program

September 7, 2012

Radiology Advocated As First Diagnostic Test After Hemoccult

April 25, 1986

Brain Tumor Research Needs Stronger Interdisciplinary Collaboration, PRG Says.

November 17, 2000

Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.

February 25, 2000

“Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer

October 10, 1975